She has advised clients on the regulatory pathway for medicines and medical devices in Europe, in particular advising on:

Clinical trials, including transparency issues

Paediatric investigation plans,

Marketing authorisations,

Orphan medicinal products,

Manufacturing and wholesale distribution authorisations,

Supply chain issues including novel direct to patient solutions,

Parallel trade

Advertising and promotion

Relations with healthcare professionals, including bribery and corruption

Pricing and market access, including NICE submissions and appeals

Product liability, including managing substantial multiparty actions.

Jacqueline has advised on a number of judicial reviews challenging regulatory decisions of both MHRA and the EMA and has defended product liability claims in the House of Lords, Supreme Court and the Court of Justice of the European Union.

Jacqueline practised medicine for 8 years before qualifying as a solicitor.